Our Team

Dr. Kane has pioneered the targeted metabolic application of red cell fatty acid analysis from a university-based laboratory over the past 25 years and has expanded into phospholipid analysis for both pediatric and adult populations, with research relating to acute as well as chronic conditions. In 2008, she applied a specialized epigenetic analysis—“a portal into the cell”—whereby images of the membrane surface, phospholipids, and mitochondria of each patient, along with their DNA adducts, were utilized to approach the patient’s epigenetic aberrations. Working with physicians in the application of bioactive lipids, the findings have revealed both improvement in the patients’ clinical status and normalization of the phospholipids per red cell analysis and membrane imaging. Dr. Kane’s work has expedited the incorporation of current research and evidence-based medicine directly into clinical practice to help resolve some of the most complex medical disorders of our time.

Having a long-standing interest in the challenging area of treating neurological disease, Dr. Kane has approached refractory disorders in a “right to try” effort, including Alzheimer’s, Autistic Spectrum Disorders, Pervasive Developmental Delay, Seizure Disorders including refractory status epilepticus, Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Inborn Errors in Metabolism/genetic disorders, Epigenetic insult, Neurotoxicity (toxic and viral encephalopathy, neurotoxic fungal exposure), Post-Stroke conditions, neuroinflammatory and autoimmune disorders, chronic infections including psychiatric disorders, Multiple Sclerosis, Motor Neuron Disease, and Parkinson’s Disease.

Present research studies include examination of red cell lipid aberrations, ceramides/lipid rafts, and deformation in the phospholipid membranes in autism, Alzheimer’s, epigenetic disorders, and various inherited diseases. Research treatment protocols include targeted lipid therapy with lipid mediators such as phenylbutyrate, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, bioactive lipids, and a membrane-stabilizing diet—nutrient-dense with bioactive lipids—directed toward stabilizing cellular, organelle, and myelin architecture to normalize organelle function and resolve the accumulation of aberrant proteins and lipids characteristic of neurological and orphan diseases.

Dr. Kane has published numerous articles, essays, book chapters, and books focusing on evidence-based medicine for over 45 years. She contributed two chapters—1) Seizure Disorders: Balancing Fatty Acids to Stabilize Brain Activity, and 2) Autistic Spectrum Disorder: Dynamic Intervention for Neuronal Membrane Stabilization (with Dr. Annette Cartaxo)—to the 2009 medical book Food and Nutrients in Disease Management, edited by a Johns Hopkins University researcher.

In 2020, another medical chapter, Nutrition and Neuromuscular Disease, was published by Dr. Kane with co-authors Edward Kane, Dr. Annette Cartaxo, and Dr. Thomas Wnorowski. This appeared in the book Physical Medicine Interventions for Skeletal and Cardiac Muscle Dysfunction, edited by Dr. John R. Bach and Dr. Michael Chiou. Their chapter focuses on neurometabolic oral, enteral, and parenteral feeding with bioactive lipids for pediatric and adult populations with neuromuscular disease. Dr. Kane and colleagues are currently writing a book titled Membrane Medicine: A NeuroMetabolic Membrane Stabilizing Approach to Neurological Disease.

Dr. Kane is an accomplished lecturer and author, presenting annually to medical societies and universities in the U.S. and abroad. Alongside a consortium of physicians, she teaches a 3-day biomedical course on Membrane Medicine, emphasizing targeted lipid therapy and nutritional biochemistry from a membrane-stabilizing perspective with neurological applications. She has presented her work at the NIH, Columbia, Johns Hopkins, University of North Carolina at Chapel Hill, University of Kansas, UMDNJ, Eidgenössische Technische Hochschule (the MIT of Europe), the Lipid Mediators in Health and Disease II Symposium, the Royal Medical Society, the EuroFed Lipid Congress, the Cardiolipin/Barth Syndrome Conference, ISSFAL, and NORD (Orphan Disease). Her innovative work has opened the doors of San Diego Children’s Hospital, Children’s Hospital of Philadelphia, The Cleveland Clinic, Boston Children’s Hospital, Kennedy Krieger Institute, Columbia, UMDNJ, Mt. Sinai, Cornell, and Harvard (2024) to neurometabolic lipid pharmacology and Membrane Medicine. Dr. Kane has also presented at Grand Rounds at Thomas Jefferson University Hospital Integrative Center and Morristown Atlantic Care Hospital in New Jersey, as well as at the New Jersey Institute for Food, Nutrition & Health.

Professional Positions:

• Senior Rhinologist and Otolaryngologist – Head and Neck Surgeon,
  St. Luke’s Medical Center, Quezon City and BGC, Taguig

• Assistant Professor, St. Luke’s Medical Center and Medical School (1995–2005)

• Past Chair, Department of ORL-HNS, Jose R. Reyes Memorial Medical Center

Leadership Roles:

• President, Philippine Society of ORL-HNS (2008)

  • Launched PASILIP KA campaign for early detection of head and neck cancer

  • Initiated HANDACOW (Head and Neck Cancer Consciousness Week), institutionalized via Presidential Order No. 1676

  • Led the society to win Most Outstanding Affiliate Society (PMA, 2009)

• Past President:

  • International Symposium of Infection and Allergy of the Nose (ISIAN), 1999

  • International Symposium on Nasal Polyposis and Rhinosinusitis, 2017

  • International Academy of Medical Specialists, 2017–2018

  • International College of Surgeons (Philippine Section), 2017–2018

  • Asian Research Symposium in Rhinology (ARSR), 1999

  • Philippine Society of Oncology

  • Philippine Academy of Rhinology, 2020–2021

Academic and International Contributions:

• Speaker at international conferences across the USA, ASEAN, Europe, Australia, South America, China, and India (keynote, plenary, symposium)

• Author of articles on rhinology and related topics, published in national and international journals

• Editor-in-Chief of Facing Cancer with C.A.R.E., a layman’s guidebook on cancer support and survivor stories

Awards and Honors:

• Young Achievers Award in Medicine, 1993

• The Outstanding Physician in Community Service (TOPICS), 1995 – for Operation Tulong sa Ilong medical missions

• ALIW Award for Medical Frontliners, 2020 – for Covid-19 education and ongoing outreach during the pandemic

• International Award in Rhinology, 2023 – for global contributions and leadership in organizing rhinologic conferences

Advocacy and Outreach Initiatives:

• 3Ps Program (Painting, Poetry, Photography) – a therapeutic project for cancer patients in Metro Manila

• Green Healing Advocacy Movement (GHAM) – an environmental health project in partnership with the International Academy of Medical Specialists, promoting climate action and clean air

A board-certified specialist in:

• Internal Medicine

• Cardiovascular Disease

• Interventional Cardiology

• Nuclear Cardiology

• Cardiovascular CT

Dr. Gerber has also completed extensive training in Age Management, Nutritional and Metabolic Medicine, Hormone Optimization, and Naturopathic Medicine. He is a certified GAPS practitioner, a clinical educator in Photobiomodulation, and an active researcher in Membrane Medicine through Neurolipid-Research.org.

Throughout his career, Dr. Gerber has served as Principal Investigator in over 25 clinical trials, covering advanced interventional cardiology procedures, pharmaceutical research, and medical device innovation. His global research collaborations span France, Japan, and the U.S., with a focus on heart disease reversal, inflammation, and cardiometabolic resilience.

Dr. Gerber’s passion lies in integrating conventional cardiology with cellular-level interventions and personalized lifestyle medicine. His dedication to root-cause healing aligns perfectly with the Cellular Health Foundation’s commitment to advancing natural and integrative approaches for chronic illness.

As a new member of our research team, Dr. Gerber will contribute his extensive expertise in:

• Cardiovascular Physiology

• Nutrigenomics

• Neuro-Lipid Medicine

to help develop leading-edge protocols for:

• Inflammation Reduction

• Mitochondrial Health

• Chronic Disease Prevention

“True health comes when we understand the body not just as a collection of organs, but as an intelligent cellular system capable of healing itself when given the right tools.”
— Dr. Lowell Gerber

Karen grew up in the San Francisco Bay Area and once she saw the film, The Miracle Worker, at age 10, knew she wanted to help children communicate and learn.

Karen completed her Bachelor’s and Master’s degree in Speech Pathology and Audiology at Arizona State University. She began her 40 years of commitment in her field, as a speech therapist and special education teacher, in both public and private schools for those who learn differently, focusing on autism spectrum. Home | Exceptional Needs Special Needs (exceptionalneedstoday.com)

Karen founded a residential school in the Sacramento Area and directed it for 20 years, helping parents nurture independence.

She believes in the art of possibility thinking. She is an author, On the Yellow Brick Road: My Search for Home and Hope for the Child with Autism: Kaplan, Karen: 9780999313503: Amazon.com: Books writer, consultant www.karenkaplanasd.com  and colleague. She currently writes for Autism Parent Magazine Autism Parenting Magazine - everything you need to support your family  and Exceptional Needs. Home | Exceptional Needs Special Needs (exceptionalneedstoday.com)